Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the ...
Per our proven model, companies with the combination of a positive Earnings ESP and a Zacks Rank #1, #2 (Buy) or #3 (Hold) ...
Zacks Investment Research on MSN
Merck (MRK) advances while market declines: Some information for investors
Merck (MRK) closed at $110.42 in the latest trading session, marking a +1.92% move from the prior day. The stock outperformed ...
Investor's Business Daily on MSN
Stock market today: Dow falls on surprise inflation data; Chevron rises, Venezuela in focus (live coverage)
Stock Market Today: The Dow Jones index dropped Friday on surprise inflation data and the Warsh nomination. Tesla rallied on ...
Merck (NYSE:MRK) has ended acquisition talks with Revolution Medicines after the parties could not agree on valuation. The ...
RIG portfolio up 3.44% YTD with 6.34% yield; review MRK, MPW, ARE & RC dividend changes and Rose Recommendations. Read here ...
Earnings watch - Notable companies due to report include Alphabet ( GOOG ), Eli Lilly ( LLY ), AbbVie ( ABBV ), Uber Technologies ( UBER ), and Qualcomm ( QCOM ). Options trading implies a ...
Bristol Myers Squibb BMY recently collaborated with clinical-stage biopharma company Janux Therapeutics to jointly develop a ...
In Europe, Danish pharmaceuticals giant Novo Nordisk (NOVO-B.CO) is set to release its full-year results, with shares on the ...
News Nation on MSN
Eli Lilly to build $3.5B plant in Pennsylvania to make drugs in US
Pharmaceutical company Eli Lilly is building a multibillion-dollar drug-making plant in Pennsylvania, in part to avoid tariff challenges with producing drugs overseas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results